Results 221 to 230 of about 1,569,447 (281)

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit   +11 more
wiley   +1 more source

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Transcatheter Edge-to-Edge Mitral Valve Repair Device Embolization into the Right Lower Pulmonary Vein. [PDF]

open access: yesJACC Case Rep
Kumi DD   +6 more
europepmc   +1 more source

Environmental Drivers of Genetic Structure and Local Adaptation in a Marine Foundation Species. [PDF]

open access: yesEcol Evol
Starko S   +7 more
europepmc   +1 more source

ThreatFedChainAI: an adaptive edge blockchain architecture for big data-driven threat analytics in IoT networks. [PDF]

open access: yesSci Rep
Ashwini N   +5 more
europepmc   +1 more source

Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring

open access: yes
Annals of Clinical and Translational Neurology, EarlyView.
Francesco Saccà, Ryan Pelto
wiley   +1 more source

Home - About - Disclaimer - Privacy